NASDAQ: ALGSAligos Therapeutics Inc Stock Ownership - Who owns Aligos Therapeutics?
Insider buying vs selling
Have Aligos Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ALGS insiders and whales buy or sell their stock.
ALGS Shareholders
What type of owners hold Aligos Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Carole Nuechterlein | 180.32% | 11,025,941 | $85.01M | Insider |
| Roche Holding Ltd | 180.32% | 11,025,941 | $85.01M | Insider |
| Vivo Capital VIII LLC | 58.01% | 3,547,030 | $27.35M | Insider |
| Versant Venture Capital VI LP | 53.84% | 3,292,339 | $25.38M | Insider |
| Holdings A. Novo | 42.76% | 2,614,563 | $20.16M | Insider |
| Wellington Biomedical Innovation Master Investors Cayman I LP | 31.17% | 1,906,191 | $14.70M | Insider |
| Lawrence Blatt | 30.52% | 1,866,092 | $14.39M | Insider |
| Leonid Beigelman | 17.10% | 1,045,346 | $8.06M | Insider |
| Thomas Woiwode | 14.18% | 866,896 | $6.68M | Insider |
| Adage Capital Partners GP LLC | 7.60% | 465,000 | $3.59M | Institution |
ALGS vs Biotech Stocks
Aligos Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.